
Please try another search
LONDON (Reuters) - British pharmaceutical firm ImmuPharma (L:IMM) said on Thursday it had signed a licensing and development agreement for Lupuzor, a first-in-class treatment for auto-immune disease...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review